The down-regulation of miR-128ab in human glioma and glioblastoma cell lines has previously been reported [46] to increase the expression of ARP5, Bmi-1 and E2F-3a, promoting neural stem cells renewal and regulate cell-cycle progression [46]. Here, BMI1 is linked to central nervous system cancer.